Synthetic Biologics logo
Synthetic Biologics SYN
$ 0.96 1.32%

Quarterly report 2024-Q3
added 11-12-2024

report update icon

Synthetic Biologics Balance Sheet 2011-2024 | SYN

Annual Balance Sheet Synthetic Biologics

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Net Debt

-22.5 M -41.3 M -65.8 M -5.75 M -14.3 M -28.9 M -17.1 M -19.1 M -20.8 M -17.5 M -14.6 M -9.95 M -6.68 M

Long Term Debt

162 K 221 K 1.4 M - - - - - - - - - -

Long Term Debt Current

487 K 216 K 124 K 287 K 249 K - - - - - - - -

Total Non Current Liabilities

- - - 186 K 473 K 302 K 12.5 M 492 K 267 K - - - -

Total Current Liabilities

6.74 M 7.06 M 3.55 M 2.97 M 5.28 M 3.38 M 9.79 M 19.8 M 15.6 M 9.59 M 1.03 M 395 K 417 K

Total Liabilities

15.5 M 17.3 M 4.96 M 3.15 M 5.75 M 3.69 M 22.2 M 20.2 M 15.8 M 9.59 M 1.03 M 395 K 417 K

Deferred Revenue

906 K - - - - - - - - - - - -

Retained Earnings

-309 M -291 M -271 M -248 M -236 M -219 M -194 M -172 M -145 M -101 M -81.3 M -68.9 M -51.9 M

Total Assets

55.2 M 71.9 M 70.4 M 8.41 M 17.2 M 30.1 M 18.8 M 22.5 M 30.8 M 19.1 M 16.3 M 13.4 M 7.48 M

Cash and Cash Equivalents

23.2 M 41.8 M 67.3 M 6.23 M 15 M 28.9 M 17.1 M 19.1 M 20.8 M 17.5 M 14.6 M 9.95 M 6.68 M

Book Value

39.7 M 54.6 M 65.4 M 5.26 M 11.5 M 26.5 M -3.41 M 2.25 M 15 M 9.56 M 15.2 M 13 M 7.06 M

Total Shareholders Equity

37 M 51.8 M 65.4 M -4.77 M 1.82 M 17.1 M -1.5 M 3.84 M 16.1 M 9.56 M 15.2 M 13 M 7.06 M

All numbers in USD currency

Quarterly Balance Sheet Synthetic Biologics

2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

Long Term Debt

1.04 M 1.16 M 1.3 M 1.44 M 150 K 153 K 160 K 221 K 202 K 216 K 229 K 1.4 M 1.4 M 1.43 M 108 K 186 K 186 K 186 K 186 K 473 K 473 K 473 K 473 K - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Total Non Current Liabilities

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Total Liabilities

15.5 M 14.7 M 14.6 M 15.5 M 17.7 M 17.7 M 17.3 M 17.3 M 20.5 M 20.7 M 21 M 4.96 M 4.56 M 3.52 M 2.23 M 3.15 M 3.15 M 3.15 M 3.15 M 5.75 M 5.75 M 5.75 M 5.75 M 3.69 M 3.69 M 3.69 M 3.69 M 10.2 M 10.2 M 10.2 M 10.2 M 20.2 M 20.2 M 20.2 M 20.2 M 15.8 M 15.8 M 15.8 M 15.8 M 9.59 M 9.59 M 9.59 M 9.59 M 1.03 M 1.03 M 229 K 1.03 M 395 K 395 K 395 K 443 K 417 K 417 K 417 K 417 K

Deferred Revenue

- - - - 525 K - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Retained Earnings

-331 M -323 M -314 M -309 M -304 M -301 M -295 M -291 M -285 M -281 M -276 M -271 M -266 M -263 M -260 M -248 M -248 M -248 M -248 M -236 M -236 M -236 M -236 M -219 M -219 M -219 M -219 M -194 M -194 M -194 M -194 M -172 M -172 M -172 M -172 M -145 M -145 M -145 M -145 M -101 M -101 M -101 M -101 M -81.3 M -81.3 M -81.3 M -81.3 M -68.9 M -68.9 M -68.9 M -68.9 M -51.9 M -51.9 M -51.9 M -51.9 M

Total Assets

40.1 M 42.4 M 48.7 M 55.2 M 61.5 M 65.4 M 67.9 M 71.9 M 78.7 M 82.3 M 89 M 70.4 M 75.1 M 77.3 M 79.1 M 8.41 M 8.41 M 8.41 M 8.41 M 17.2 M 17.2 M 17.2 M 17.2 M 30.1 M 30.1 M 30.1 M 30.1 M 18.8 M 18.8 M 18.8 M 18.8 M 22.5 M 22.5 M 22.5 M 22.5 M 30.8 M 30.8 M 30.8 M 30.8 M 19.1 M 19.1 M 19.1 M 19.1 M 16.3 M 16.3 M 16.3 M 16.3 M 13.4 M 13.4 M 13.4 M 13.4 M 7.48 M 7.48 M 7.48 M 7.48 M

Cash and Cash Equivalents

16.4 M 16.6 M 18.3 M 23.2 M 31.2 M 34.2 M 36.1 M 41.8 M 50.5 M 52.3 M 56.7 M 67.3 M 72.1 M 74.3 M 76.9 M 6.23 M 6.23 M 6.23 M 6.23 M 15 M 15 M 15 M 15 M 28.9 M 28.9 M 28.9 M 28.9 M 17.1 M 17.1 M 17.1 M 17.1 M 19.1 M 19.1 M 19.1 M 19.1 M 20.8 M 20.8 M 20.8 M 20.8 M 17.5 M 17.5 M 17.5 M 17.5 M 14.6 M 14.6 M 14.6 M 14.6 M 9.95 M 10 M 10 M 9.6 M 6.68 M 5 M 8.39 M 6.68 M

Book Value

24.6 M 27.6 M 34.1 M 39.7 M 43.9 M 47.8 M 50.6 M 54.6 M 58.1 M 61.7 M 68 M 65.4 M 70.6 M 73.7 M 76.8 M 5.26 M 5.26 M 5.26 M 5.26 M 11.5 M 11.5 M 11.5 M 11.5 M 26.5 M 26.5 M 26.5 M 26.5 M 8.64 M 8.64 M 8.64 M 8.64 M 2.25 M 2.25 M 2.25 M 2.25 M 15 M 15 M 15 M 15 M 9.56 M 9.56 M 9.56 M 9.56 M 15.2 M 15.2 M 16 M 15.2 M 13 M 13 M 13 M 13 M 7.06 M 7.06 M 7.06 M 7.06 M

Total Shareholders Equity

24.6 M 25.9 M 31.4 M 37 M 41.2 M 45 M 47.9 M 51.8 M 56.4 M 62.2 M 68 M 65.4 M 70.6 M 73.7 M 76.8 M -4.77 M -4.77 M -4.77 M -4.77 M 1.82 M 1.82 M 1.82 M 1.82 M 17.1 M 17.1 M 17.1 M 17.1 M -1.5 M -1.5 M -1.5 M -1.5 M 3.84 M 3.84 M 3.84 M 3.84 M 16.1 M 16.1 M 16.1 M 16.1 M 9.56 M 9.56 M 9.56 M 9.56 M 15.2 M 15.2 M 15.2 M 15.2 M 13 M 13 M 13 M 13 M 7.06 M 7.06 M 7.06 M 7.06 M

All numbers in USD currency